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This paper builds on my earlier work which has examined privacy issues as these relate to genetic 
material and information derived from that material.1 In that work I have argued that a more 
robust concept of privacy is required than is currently available to allow us to meet to challenges 
posed by increased availability of genetic information. I have argued that existing medico-legal 
paradigms, such as respect for individual autonomy and protection of patient confidentiality, do 
not provide adequate protection of the range of interests that individuals might have in their 
genetic constitution. Accordingly, I have proposed a new model of privacy protection that seeks 
to complete the family of values that I believe should work in parallel to provide such protection. 
However, although I am generally ‘pro-privacy’, I also recognise that the limitations of privacy, 
both in theory and in practice. One such limitation is that a privacy right - however conceived -
is always a right of non-interference. It does not constitute a right of positive entitlement. To this 
extent, privacy suffers from limitations similar to those that afflict the principle of respect for 
autonomy, namely, it does not provide for any continuing control over personal matters once they 
enter the public sphere. Autonomy in the guise of consent reduces control to the giving or 
withholding of that consent after which an individual is largely powerless to dictate what 
happens.2 Thus, for example, while an individual might consent to make private information 
public, she will have no continuing control over what is then done with her data. Similarly, if an 
individual consents to provide tissue samples for research purposes she loses control of those 
samples for all time coming. She is not in a position to dictate the fate of the samples by 
                                                
1 GT Laurie, Genetic Privacy: A Challenge to Medico-Legal Norms, Cambridge University Press, 2002. I am grateful to the 
publishers for allowing elements of chapter 6 of this monograph to be reproduced here. A version of this paper was 
given at the IASTED Law and Technology International Conference in Boston, Massachusetts in November 2002. 
2 See further, O O’Neill, Autonomy and Trust in Bioethics, Cambridge University Press, 2002.
2
exercising her right to privacy. And, while her privacy in any information derived from those 
samples may continue to be protected, any residual authority depends on the nature of her 
original consent and, more importantly, on the assumption that its terms will not be violated. 
Privacy and autonomy are, therefore, of limited utility in this respect. They are, however, unified 
at the fundamental level by the fact that each reflects a valued aspect of the human personality.3
If, however, we find them inadequate guardians of ‘self’, we should explore other options - as yet 
largely uncharted - that may give fuller protection to interests in the persona. German law, for 
example, protects the body as an aspect of the right to personality. So, if interference occurs with 
excised parts of the body - such as the unauthorised destruction of sperm - the law will provide a 
remedy for a breach of the Persönlichkeitsrecht.4 The way this is done is by recognising enforceable 
property rights in excised human material.5 Anglo-American law is less sophisticated in this 
regard. Our tendency has been to treat privacy and autonomy as one branch of protection, and 
property as another. Numerous examples of this can be given. Most notable is the experience in 
Oregon, where the state took the bold step in 1995 of embodying a personal property right in 
genetic information and DNA samples when used for anonymous research with the result that 
that unauthorised interference with either constituted a tort actionable at law.6 However, after 
several years of lobbying by the pharmaceutical industry and research institutes, a new Bill was 
passed in June 2001 that removed this right and replaced it with more stringent privacy 
protection.7 The claim is that Oregon will now have the most far-reaching privacy legislation of 
its kind in the United States. The reality is that the two concepts of privacy and property are 
treated as ‘either/or’ options when there is no sound reason to do so. The Oregon experiment 
was not given sufficient time for the promise and the pitfalls of a property paradigm to be 
                                                
3  The European Group on Ethics in Science and New Technologies to the European Commission recognises the 
same connection between personal health data and personality, see, Opinion of the EGE, Ethical Issues of 
Healthcare in the Information Society (Opinion No.13, July 1999), para.2.2.
4 Bundesgerichtshof, 9 November 1993, BGHZ, 124, 52. 
5 Excised body parts that are not intended for another (such as transplant organs) or for return to the individual 
(such as stored sperm), are subject to the normal rules of personal property, ibid.
6 ORS 659.700-720. 
7 Senate Bill 114 was before the 71st Oregon Legislative Assembly (8 January - 7 July 2001).
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explored and addressed. In the UK, the Human Genetics Commission8 has recently issued its 
recommendations on protecting personal genetic data, but it too has eschewed the property 
paradigm in favour of an approach couched in the traditional concepts of ‘more and better 
consent’, and ‘adequate protection of privacy interests’.9 This would not be so objectionable but 
for the fact that property rights are granted over human material. This happens all the time, and
is actively encouraged by governments around the world. It happens, of course, through the 
mechanisms of intellectual property law, and primarily through the granting of patents. But the 
property owners in such cases, as the infamous Moore case demonstrated only too well,10 are the 
‘inventors’ - i.e. the researchers, and not the subjects from whom the material was derived. Much 
has been written about the inequities of this, and it has even prompted the Human Genome 
Organisation’s Ethics Committee admirably to recommend that: ‘‘profit-making entities dedicate 
a percentage (e.g 1-3%) of their annual net profit to healthcare infrastructure and/or to 
humanitarian efforts’.11 However, in this short paper I would like to propose an alternative 
strategy, namely, recognition of property rights in ourselves. 
The need for an additional approach?
One might ask why is such a strategy needed? A number of points can be made. There is, for 
example, an undeniable public crisis of confidence in genetic research, even though its promise is 
well recognised. This is borne out by the UK Medical Research Council’s survey into public 
perceptions of the collection of human biological samples - published in October 2000.12 This 
                                                
8 Human Genetics Commission, Inside Information: Balancing Interests in the Use of Personal Genetic Data (May 2002).
9 See also, Article 4 of the Universal Declaration on the Human Genome and Human Rights provides: ‘the human 
genome in its natural state shall not give rise to financial gains’, while Article 21 of the Council of Europe 
Convention on Human Rights and Biomedicine states: ‘The human body and its parts shall not, as such, give rise to 
financial gain’.
10 Moore v. Regents of the University of California 793 P.2d 479 (Cal. 1990), 271 Cal. Rep. 146. 
11 HUGO Ethics Committee, Statement on Benefit-Sharing (Vancouver, 9 April 2000).
12 Medical Research Council, Public Perceptions of the Collection of Human Biological Samples (MRC, London, 2000). See 
too,  Human Genetics Commission, Public Attitudes to Human Genetic Information (HGC, London, 2001), pp.20-22.
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general atmosphere of mistrust is compounded in large part by the increased role that the private 
sector has assumed in undertaking, financing and staking a claim to research involving human 
genetic material. The granting of intellectual property rights over the products of this research 
has served only to alienate the public even further. These issues will not be addressed adequately 
just by the simple removal of intellectual property protection from the equation. Pragmatically, 
this is not even a viable option, but more importantly the very strong public interest in 
encouraging innovation would be lost to any state or geographical area that attempted to use it; 
the research and innovation that biotechnology attracts would simply move elsewhere. The real 
problem is two-fold. First, where should the proper focus lie in addressing this crisis of 
confidence? Second, what role, if any, should law play in that process? 
The reality is that those who participate as subjects and who provide vital genetic 
research material are the key components of the genetic research machine and are crucial to its 
continued success. Whether they are represented by individuals or by communities, they are 
currently undervalued, under respected and undermined. The way forward is to empower these 
parties to take a more equal role in the partnership that is formed when they participate in 
research.13 The starting point is to break free of current institutional constraints that stand in the 
way of this progress and to explore more imaginative ways by which we can establish, and 
perhaps protect, the role of those who further the public interest in genetic research.              
Maybe so, but why property? Well, the exclusion of individuals from the human property 
model, when this model is available to others, has been strongly objected to by many who 
advocate a more consistent application of the law.14 This in turn is part of a wider movement 
                                                
13 H.T. Greely, ‘The Control of Genetic Research: Involving the “Groups Between”’ (1998) 33 Houston Law Review
1397.
14 See, for example, D. Beyleveld and R. Brownsword, ‘My Body, My Body Parts, My Property?’ (2000) 8 Health Care 
Analysis 87, J.W. Harris, Property and Justice (Clarendon Press, Oxford, 1996), and D. Morgan, Issues in Medical Law and 
Ethics (Cavendish, London, 2001), chapter 6.  
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that involves a re-assessment of the relationship that individuals enjoy with their own bodies and 
the legal rights that can be claimed in respect of that relationship.15
Moreover, current models are inadequate to redress imbalances. The conflation of 
autonomy with consent that is typical of current approaches to medico-legal dilemmas reduces 
the means of respecting individuals to one solitary event - the obtaining of informed consent. 
And, while numerous ways of maintaining respect for individuals are available when they remain 
passive in the process,16 the equiparation of autonomy with consent means that informed 
consent has come to be the primary, and arguably the only, legitimate way of empowering
individuals in their dealings with health care professionals and researchers. This is also true in the 
spheres of intellectual property and biotechnology. But this need not and should not be so. Two 
examples illustrate the current approach.
When the European Patent Office’s Opposition Division was called upon in 1994 to 
examine the morality of Howard Florey’s patent over the H2-Relaxin - a protein secreted by 
pregnant woman that eases the process of childbirth - it did so in large part by reference to the 
principle of informed consent.17 It had been objected, inter alia, that the granting of the patent 
offended morality because it required the removal of tissue from pregnant women; this was said 
to be an affront to human dignity because it used a particular female condition (pregnancy) for a 
technical process oriented towards profit. The answer of the Opposition Division, however, was 
that the tissue had been freely donated by the women in question, and that, therefore, the 
manipulation of genetic material from those samples was not immoral.18
Second, Recital 26 of the European Directive on the legal protection of biotechnological 
inventions provides that:
                                                
15 See further, J.I. de Witte and H. ten Have, ‘Ownership of Genetic Material and Information’ (1997) 45 Social 
Science and Medicine 51.
16 Examples include doing no harm and respecting individual privacy.
17 HOWARD FLOREY/Relaxin [1995] EPOR 541.
18 ibid., at 550. It was left open, however, whether the research in se was immoral, but this was not addressed by the 
Division as it is a question outside its remit (the remit being to determine whether the granting of a patent would be 
immoral).
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Whereas if an invention is based on biological material of human 
origin or if it uses such material, where a patent application is 
filed, the person from whose body the material is taken must have 
had an opportunity of expressing free and informed consent 
thereto, in accordance with national law. 19
The terms of Recital 26 were originally intended for inclusion as an Article of the Directive with 
clear binding force on member states, but heavy lobbying by representatives of the 
biotechnology and patent industries meant that it was ultimately relegated to the Preamble to the 
Directive, where its legal status and its effect on member states is far less certain.20  
None the less, such formulations of consent certainly provide adequate protection for 
the researchers. They also represents one means of respecting individuals. Indeed, they are highly 
desirable safeguards. However, they are considerably less successful as a means of empowering 
individuals. But, it might be asked, why would we be concerned to empower individuals anyway? 
Well, it is precisely because people feel disenfranchised from, and disempowered by, the modern 
machinery of research that we face the current public crisis of confidence in research in general 
and genetic research in particular. Individuals who provide samples for research purposes are 
not, and do not feel like, stake-holders in the enterprise. The continued participation and support 
of the public in research activity can only be ensured by a fundamental reappraisal of the 
relationships with the subjects that have traditionally been accepted.
The imperative to seek and obtain consent from research subjects gives them an illusion 
of power and control. In reality, it delegates extremely limited control to individuals. The sole 
power that is afforded is that to withhold consent - that is, to refuse. Moreover, there is no 
                                                
19 Directive 98/44/EC.
20 For a trenchant critique, see D. Beyleveld, ‘Why Recital 26 of the E.C. Directive on the Legal Protection of 
Biotechnological Inventions Should Be Implemented in National Law’ (2000) 4 Intellectual Property Quarterly 1.  
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residual power once consent has been given unless further consent is required at some future 
point. This is demonstrated particularly well in the context of the donation of samples for 
research. While no individual will be forced to give samples - and in most cases the only ethically 
and legally appropriate approach is to seek informed consent to the provision of a sample - the 
individual retains no continued relationship with the sample in either a factual or a legal sense 
once consent has been obtained and the sample surrendered. Thus, the focus on consent renders 
the participatory process disempowering in at least two senses: (i) for those who genuinely wish 
to participate in research the availability of a ‘right to refuse’ is useless; (ii) the one-off event of 
consent is disempowering because it fails to recognise the individual subject - or indeed, the 
community of research subjects - as a party with an interest in the overall endeavour. In sum, the 
fundamental problem with the consent model is that it does not provide a means by which the 
subjects can exercise continuing control of her materials.21
Revisiting the gift model
This problem is compounded by the continuing use of the gift model that has traditionally 
served to govern the researcher-subject relationship. The notion of gift has a strong normative 
appeal in lay terms, not least because it is seen to be a laudable act, demonstrating the virtues of 
altruism and beneficence, and untainted by the twin evils of self-interest or exploitation. In 
practice, it has considerable utility for the recipient, in that gifts for research purposes are treated 
as unconditional. This provides broad scope for the future use or disposal of the gift. As to 
public interest, unconditional gifting can serve a number of valuable social ends, including 
advances in medical research and the development of therapeutic agents or cures. This particular 
consideration weighs heavily as an unquestionable given, to which we shall return presently. But 
                                                
21 For a defence of the role of autonomy and consent as a counter to property claims, see L. Skene, ‘Proprietary 
Rights in Human Bodies, Body Parts and Tissue: Regulatory Climates and Proposals for New Laws’ (2002) 22 Legal 
Studies 102.
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such a concept of gift is seriously incongruous in legal terms. In English law ‘gift’ is defined as 
‘the transfer of any property from one person to another gratuitously’22 [emphasis added]
Thus, in legal terms the invocation of gift presupposes underlying property rights in the 
subject matter that constitutes the gift. As a result, the legal position in respect of ownership of 
donated human body parts is in disarray in most western legal systems.23 A fair summation is 
that while there is no clear prohibition on ownership of body parts - and indeed, one can find 
many examples of a property model being applied to human tissues - the one player who is 
routinely excluded from the property model is the source of the property itself.24
The classic policy decision on self-ownership is to be found in the decision of the 
Supreme Court of California in Moore v Regents of the University of California,25 in which the 
Calfiornian Supreme Court denied the plaintiff any legal recognition of property rights in his 
own excised spleen cells. The court held that because no precedent could be found on which to 
ground Moore’s property claim, and because of the utilitarian consideration that a finding for the 
plaintiff would be a hindrance to medical research ‘by restricting access to the necessary raw 
materials’,26 it was inappropriate to recognise individual property rights in the body. Moreover, 
the Court was concerned that a contrary decision would ‘[threaten] to destroy the economic 
incentive to conduct important medical research’ because ‘[i]f the use of cells in research is a 
conversion, then with every cell sample a researcher purchases a ticket in a litigation lottery’.27
The paradox in this decision was highlighted by the dissent of Broussard, J. wherein he stated:
                                                
22  Halsbury’s Laws of England, Fourth Edition, Vol. 20: Gifts, paragraph 1.
23 For a discussion, see J.K. Mason and R.A. McCall-Smith, Law and Medical Ethics (6th edn, Butterworths, 
Edinburgh, 2002), chapter 15. 
24 See, J.K. Mason and G.T. Laurie, ‘Consent or Property? Dealing with the Body and its Parts in the Shadow of 
Bristol and Alder Hey’ (2001) 64 Modern Law Review 711.
25 Moore v. Regents of the University of California 793 P.2d 479 (Cal. 1990), 271 Cal. Rep. 146. See too, Brotherton v.
Cleveland 923 F.2d 661 (6th Cir. 1991).
26 Moore, Cal. Rep. at 161.  
27 ibid., at 162-163. 
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...the majority’s analysis cannot rest on the broad proposition that 
a removed part is not property, but rather rests on the 
proposition that a patient retains no ownership interest in a body 
part once the body part has been removed from his or her body.28
Does it remain reasonable or defensible to exclude completely from the equation the one person 
who can make everything possible?
More particularly, it is interesting to note how the court in Moore seemed entirely satisfied 
that its adoption of the consent model was sufficient to provide respect for, and to empower, the 
plaintiff (for Moore won in respect of lack of informed consent). The consent model and the 
property model were treated as though they were mutually exclusive; a phenomenon that has 
also been noted above in respect of property and privacy. There is, however, no sound reason 
why this should be so.
A property paradigm
It is undeniable that an attitudinal shift is occurring in respect of the way we regard our bodies 
and any parts removed from them. The recent MRC survey on the perceptions of the public on 
the collection and use of human biological samples found that younger people tended to view 
payment for excised bodily tissues as a matter of right or at least as a logical and acceptable 
option.29 This was especially so when research was undertaken for profit by private enterprises. 
In corroboration, the Human Genetic Commission’s poll found considerable antipathy to the 
idea of exclusive ownership of genetic information by research organisations.30 Contrariwise, 
                                                
28 ibid., at 168. For comment on Moore see, B. Hoffmaster ‘Between the Sacred and the Profane: Bodies, Property, 
and Patents in the Moore Case’ (1992) 7 Intellectual Property Journal 115.
29 Medical Research Council, Public Perceptions of the Collection of Human Biological Samples (MRC, London, October 
2000).
30 Human Genetics Commission, Public Attitudes to Human Genetic Information, pp.27-28.
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members of the older generation found more comfort in the classic gift paradigm, expecting 
nothing in return for altruistic and public spirited donations.31 And yet, many GPs and nurses 
who took part in the survey also supported the view that volunteers should retain a degree of 
ownership in donated samples.32 Indeed, the MRC Working Group on Human Tissue and 
Biological Samples for Use in Research opined: ‘...it was more practical and more attractive from 
a moral and ethical standpoint to adopt the position that, if a tissue sample could be property, 
the original owner was the individual from whom it was taken’.33
It is submitted that there is nothing in principle to prevent recognition of property 
interests in aspects of the self, subject of course to limitations against self-harm. A personal 
property paradigm could, in fact, serve an all important role in completing the picture of 
adequate protection for the personality in tandem with other protections such autonomy, 
confidentiality, and privacy.34 However, the added value of a property model lies in its ability to 
empower individuals and communities and to provide the crucial continuing control over 
samples or information through which on-going moral and legal influence may be exerted.  
Property implies many things, including ownership and control. Property protection is, 
however, by no means an absolute, and as with all of our other legal rights, property rights can 
be tempered in our own interests or in those of others. Exercises of self-ownership therefore 
need not be recognised if these conflict with an individual’s best interests. Examples include 
attempts to dispose of vital organs or tissues that would be detrimental to health. Nor should the 
law ever condone ownership of entire living, breathing human beings as this would be a fortiori 
impermissible as slavery. None the less, the recognition of property rights in excised body parts 
or samples does not carry any of these risks.  
                                                
31 ibid., para. 6.12.
32 ibid., para. 17.
33 Medical Research Council, Working Group on Human Tissue and Biological Samples for Use in Research: Report of the 
Medical Research Council Working Group to Develop Operational and Ethical Guidelines (MRC, London, 1999), para. 2.2.1.
34 A.D. Moore, ‘Owning Genetic Information and Gene Enhancement Techniques: Why Privacy and Property 
Rights May Undermine Social Control of the Human Genome’ (2000) 14 Bioethics 97.
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The way that the concept of gift has been used in research culture presumes surrender of 
all residual interests in donated samples. However, not only does this lack support in law but it 
has also prompted the dual disservices of justifying a distorted gift paradigm while fuelling 
inconsistencies that ultimately undermine public confidence in research.35
It is no longer clear that the model of gifting currently employed in the modern research 
environment remains appropriate. It is not true, for example, that individuals retain no interest in 
materials surrendered for research. The moral significance of body parts remains even when they 
are separated from their original source. The MRC has found, for example, that: ‘[v]irtually 
everyone said that if they donated a sample they would appreciate feedback on what the research 
using their samples had discovered or achieved’.36
Nor should we ignore the fact that the commercial value that human material might 
represent to researchers also represents a potential value in those terms to the sample sources 
themselves. Not everyone agrees with the Supreme Court of California in Moore.37 Numerous 
commentators point to principles of fundamental equity, the redress of unjust enrichment and 
the protection of personal interests that can be furthered through property rights.38
The recognition of this kind of interest in personal samples would provide the 
continuing control that is so lacking under the consent model alone.39 Meaningful, legally 
relevant and enforceable conditions could be placed on any transfer of the property and so 
ensure that a research participant or indeed a community retains a vested interest in samples and 
in the goals and outcomes of any research for which those samples are provided. By the same 
token, restrictions on the inclusion of undesirable clauses by either side could easily be imposed 
                                                
35 Mason and Laurie, ‘Consent or Property?’. 
36 MRC, Public Perceptions, para. 6.9.
37 M.M.J. Lin, ‘Conferring a Federal Property Right in Genetic Material: Stepping into the Future with the Genetic 
Privacy Act’ (1996) 22 American Journal of Law and Medicine 109.
38 See, for example, Beyleveld and Brownsword, ‘My Body, My Body Parts, My Property?’, W. Boulier, ‘Sperm, 
Spleens and Other Valuables: The Need to Recognize Property Rights in Human Body Parts’ (1995) 23 Hofstra Law 
Review 693, and C.M. Valerio Barrad, ‘Genetic Information and Property Theory’ (1993) 87 Northwestern University 
Law Review 1037.
39 E.B. Seeney, ‘Moore 10 Years Later - Still Trying to Fill the Gap: Creating a Personal Property Right in Genetic 
Material’ (1998) 32 New England Law Review 1131.
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by law.40 It might be objected, for example, that property rights could easily be waived under 
pressure. The obvious retort to this is that no such assignation of rights should be legally 
permissible. Thus, while individuals or communities might choose not to exercise their rights, 
they cannot give them away.       
Current movements towards a property model
Examples of communities working together can be found in North America where families have 
used their genetic uniqueness as a bargaining tool. Those suffering from the rare genetic disorder 
Pseudoxanthoma elasticum (PXE) have reached agreement with researchers only to provide 
samples only on the condition that they are named as joint-patentees in any subsequent patent 
applications, with a right to 50% of any proceeds.41 This is an interesting reversal of fortune, for 
historically researchers would not take samples unless the consent included a grant of full title, 
even if this was meaningless in law. That such a bargain has been struck signals an important 
change in research culture, although the point remains that the property interests claimed by the 
families and their representatives may be unfounded in law. Fundamental principles of justice 
certainly support this approach,42 but whether it could withstand serious legal analysis is open to 
debate.43 Nevertheless, more such arrangements will undoubtedly be made. 
The reader should not take away from this discussion an impression that the property 
model being advocated amounts only to some crude instrument requiring that research subjects 
be paid for their trouble. Rather, it is offered as a vehicle for further discussion and analysis of 
certain crucial elements that must be strengthened in order to advance the public interest in 
genetic research. A cultural shift in attitude must occur, as must a reassessment the nature of the 
                                                
40 On experiences to date of applying contract law to reproductive materials, see D.M. Vukadinovich, ‘Assisted 
Reproductive Technology Law: Obtaining Informed Consent for the Commercial Cryopreservation of Embryos’ 
(2000) 21 Journal of Legal Medicine 67.
41 http://www.pxe.org/
42 HUGO Ethics Committee, ‘HUGO Urges Genetic Benefit-Sharing’ (2000) 3 Community Genetics 88.
43 B.M. Knoppers, ‘Population Genetics and Benefit Sharing’ (2000) 3 Community Genetics 212.
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relationship between researchers and subjects. These can be achieved in part through the 
discourse of property. 
The language that we use predisposes us to certain attitudes towards each other and 
serves to establish the nature and the limits of any claims that we might make of each other. The 
law has the power to legitimise some of these claims by giving them the status of enforceable 
rights. We ought, then, to consider what it would mean to talk in terms of property rights in 
ourselves and how that language might be translated into law. 
At the time of writing a seminal case is proceeding through the American courts brought 
by parents of children affected by Canavan disease against researchers who developed and 
patented a test for the disorder using samples donated by the families.44 The defendants had 
worked closely with afflicted families receiving samples and gaining access to registers containing 
details of other affected groups around the world. However, when the Canavan gene was 
eventually identified the researchers sought a patent over it and a related test and proceeded to 
restrict access to the latter save through tightly controlled exclusive licences. The plaintiffs
objected strongly and have mounted an action on a number of grounds. These include, lack of 
informed consent, breach of fiduciary duty, and conversion. In this last respect, the plaintiffs 
claim a property interest in their samples, the genetic information therein and information 
contained in the Canavan Registry. 
Paradoxically, this case stands in stark contrast to Moore, for here policy favours the 
plaintiffs. The families want information about the disease and the test to be freely available 
while it is the patent holders who wish to restrict access and so potentially hinder research. Policy 
will undoubtedly have a significant role to play in the outcome, but the policy arguments are 
strong on both sides,45 and attitudes have moved on since Moore was decided in 1990.46,47
                                                
44 Greenberg et al. v. Miami Children’s Hospital Research Institute Inc. et al., (2003), pending. Jurisidctional issues were 
settled at Illinois (Eastern Division) District Court, (2002) WL 1483266 (N.D.Ill.). 
45 Cf. A. Ryan, ‘Self-Ownership, Autonomy and Property Rights’ (1994) 11 Social Philosophy and Policy 241, and S.R. 
Munzer, ‘An Uneasy Case Against Property Rights in Body Parts’ (1994) 11 Social Philosophy and Policy 259.
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Defending a property model
A number of counter-arguments can, however, be mounted. The concern that property rights in 
the self will hinder research held sway in Moore and lie at the core of the amendments to the 
Oregon law. However, it is far from established fact that research will be obstructed by 
furnishing sample sources with some small measure of bargaining power. Indeed, in the scheme 
of relative powers, those who provide the samples are at by far the greatest disadvantage. In 
most cases individuals would find that their property was of very little economic significance to 
researchers. But more positively, it has been suggested that research might be furthered rather 
than hindered by the recognition of property rights because those previously reluctant to come 
forward now have an incentive to do so.48 Furthermore, the mere recognition of property does 
not preclude altruistic gifting.
The second major counter-argument is, of course, that commercialisation of body parts 
leads to the prospect of exploitation. This is undoubtedly true. But, merely because we face that 
prospect is no reason in se to refuse to recognise property rights as a matter of principle. 
Exploitation can be guarded against. Indeed, it is naïve to imagine that a black market in body 
parts does not already exist. It most certainly does.49 To ignore the reality does not make it go 
away. Moreover, this argument is open to significant challenge as an example of undue 
                                                                                                                                                       
46 In Hecht v. Superior Court 20 Cal. Rptr. 2d 275 (1993), quoting Davis v. Davis 842 SW 2d 588 (1992), the California 
Court of Appeals held that stored sperm ‘occupies an interim category that entitles them to special respect because 
of their potential for human life’, but that none the less a deceased donor had an interest ‘in the nature of 
ownership, to the extent that he had a decision making authority as to the sperm...which falls within the broad 
definition of property in the Probate Code’, ibid., at 281.
47 There is tentative Australian authority that stored human tissue can be the property of those from whom it was 
taken and their heirs, see Roche v. Douglas [2000] WASC 146. Note, however, that the Australian Law Reform 
Commission and the Australian Health Ethics Committee have recommended that ‘The common law right to 
possession of preserved samples, which is currently enjoyed by hospitals and others, should continue to be upheld, 
but full property rights in genetic samples should not be granted’, see ‘Protection of Human Genetic Information’,  
Discussion Paper 66, August 2002, chapter 17.
48 M.M.J. Lin, ‘Conferring a Federal Property Right in Genetic Material: Stepping into the Future with the Genetic 
Privacy Act’ (1996) 22 American Journal of Law and Medicine 109.
49 For an indication of the scale of the problem see - Organ Watch -
  http://sunsite.berkeley.edu/biotech/organswatch/
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paternalism. As Andrews has argued in the context of surrogacy, it may be more devaluing to 
persons not to recognise their worth in monetary terms for the contributions they can make to 
society from the use of their bodies than it is to protect them from potential predators -
provided, always, that the value that they represent is not entirely reducible to those terms.50
The exploitation argument also provides an example of an overly pessimistic view of the 
utility of self-ownership rights. Rather than prejudicing individual interests, the recognition of 
property rights can bolster the respect that individuals deserve and can at the same time provide 
a crucial means of ensuring that that respect endures. The wholesale application of a traditional 
property model to the human body and its parts is not, however, envisioned. This would be 
inappropriate and unacceptable in many respects. Yet, to the extent that a body property model 
reflects a desire and need to protect the human personality, certain key features of the language 
and operation of property rights could serve this end very well.51
 Researchers might object, however, that it would be impossible to monitor individuals’ 
samples for these would invariably become mixed with others during the research process. But 
this is not problematic in property terms. The concepts of commixtion and confusion are well 
established in property law.52 Where two separate entities are mixed together and cannot be 
separated, property in each element ceases and is replaced by common property in the resulting 
mixture. The new property is owned by each of the interested parties and must be held in trust 
for the benefit of all. So, if two piles of corn (solids are governed by commixtion) or two bottles of 
wine (liquids are examples of confusion) are merged the resulting property is owned in common by 
the owners of the original elements. So too is could be with genetic samples. Indeed, the notion 
that property is to be held in trust is entirely apposite in this modern context. The benefits to be 
derived from the new property should accrue to all of those who have contributed. Alternatively, 
                                                
50 L.B. Andrews, ‘Beyond Doctrinal Boundaries: A Legal Framework for Surrogate Motherhood’ (1995) 81 Virginia 
Law Review 2343.
51 See, for example, M.B. Bray, ‘Personalizing Personalty: Toward a Property Right in Human Bodies’ (1990) 69 
Texas Law Review 209.
52 This terminology is drawn from Scots law, however, the concepts are well recognised in the laws of most western 
legal systems.
16
specification might occur when a new thing has been created without the knowledge or consent 
of the original owners, for example, where A builds a new house using B’s bricks. B cannot claim 
the return of her bricks in such a case but she is nevertheless entitled to compensation for her 
loss. So too, once again, it might be with genetic samples. Matters may be more problematic, 
however, in the context of the ownership of information derived from samples. As has been 
stated, information is a difficult concept to fit into the property paradigm, but it is by no means 
impossible to do so.53 Collective claims to property in information - such as familial genetic 
information - might therefore also arise. 
                                                
53 For an argument in support of this, see Valerio Barrad, ‘Genetic Information and Property Theory’. 
